ArticleAging cell2026
An Aging Clock Based on Immune Repertoire Features: COVID-19 Accelerates Aging.
Article in Aging cell, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
14 authors.
Funding
Abstract
Aging induces immunosenescence, a progressive decline in immune function underpinning age-related pathogen vulnerability, yet T/B cell receptor (TCR/BCR) repertoire remodeling during aging remains incompletely characterized, especially in non-European populations. Additionally, SARS-CoV-2 may perturb immune homeostasis and accelerate aging, but its impact on immune repertoire aging is unclear. Here, we analyzed leukocyte DNA from 195 healthy Chinese individuals (25-93 years) and 94 post-COVID-19 cases via CDR3 high-throughput sequencing. Aging correlated with shorter CDR3 sequences, reduced VDJ gene/V-J combination diversity, declining TCR/BCR clonotype counts (179.7/507 per 3 years), expanded hyperexpanded TCR/large BCR clones, and reduced diversity (critical turning point ~60 years). These changes were intensified post-COVID-19, with altered amino acid usage, diminished diversity, and expanded SARS-CoV-2/Mycobacterium tuberculosis-related clones. We developed a LightGBM-based immune repertoire aging clock, validating accelerated biological aging (increased cAgeDiff) and reduced intrinsic capacity in post-COVID-19 individuals. Our findings reveal age-dependent immune repertoire remodeling exacerbated by COVID-19, deepening understanding of immunosenescence and post-viral dysfunction, with potential clinical applications for age-related immune decline and post-COVID-19 syndromes.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.